Evotec, a drug discovery alliance and development partnership company, and privately funded nonprofit the Jain Foundation have extended and expanded their research collaboration leveraging Evotec's assay development and screening capabilities to support the Jain Foundation's goals of understanding and curing dysferlinopathy.

Dr. Mario Polywka, chief operating officer of Evotec, said, “This collaboration highlights both the increasing role foundations play in delivering solutions for unmet medical needs and also how Evotec's discovery platform can be leveraged in support of these goals.”